Figure 1: Medicare Expenditures on and Administrations of Part B Drugs, by Payment Methodology (2014)
This image is excerpted from a U.S. GAO report:
www.gao.gov/products/GAO-16-594
MEDICARE PART B: CMS Should Take Additional Steps to Verify Accuracy of Data Used to Set Payment Rates for Drugs
Note: In 2014, Medicare spent about $24 billion on approximately 74 million administrations of 814 Part B drugs. These estimates include spending by the Medicare fee-for-service program, its beneficiaries, and other payers in cases where Medicare is not the primary payer or where beneficiaries receive assistance with their cost sharing. These estimates do not include spending for or administrations of drugs for which Medicare's payment is bundled with that of a related service—approximately 88 million administrations in 2014—or spending for the administration or dispensing of the drugs.
Figure 1: Medicare Expenditures on and Administrations of Part B Drugs, by Payment Methodology (2014)
This image is excerpted from a U.S. GAO report:
www.gao.gov/products/GAO-16-594
MEDICARE PART B: CMS Should Take Additional Steps to Verify Accuracy of Data Used to Set Payment Rates for Drugs
Note: In 2014, Medicare spent about $24 billion on approximately 74 million administrations of 814 Part B drugs. These estimates include spending by the Medicare fee-for-service program, its beneficiaries, and other payers in cases where Medicare is not the primary payer or where beneficiaries receive assistance with their cost sharing. These estimates do not include spending for or administrations of drugs for which Medicare's payment is bundled with that of a related service—approximately 88 million administrations in 2014—or spending for the administration or dispensing of the drugs.